Commentary: Reconsidering Pharmaceutical Research and Development Investments

por Gagnon, Marc-André
Publicado 2023

Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"

por Gagnon, Marc-André
Publicado 2020

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States

por Gagnon, Marc-André, Lexchin, Joel
Publicado 2008

CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs

por Lexchin, Joel, Gagnon, Marc-André
Publicado 2014

Time to improve transparency at Health Canada’s Pest Management Regulatory Agency

por Gagnon, Marc-André, Bacon, Marie-Hélène
Publicado 2023

Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016

por Gagnon, Marc-André, Volesky, Karena D.
Publicado 2017

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada

por Morgan, Steven G., Gagnon, Marc-André, Mintzes, Barbara, Lexchin, Joel
Publicado 2016

Poisoning Regulation, Research, Health, and the Environment: The Glyphosate-Based Herbicides Case in Canada

por Bacon, Marie-Hélène, Vandelac, Louise, Gagnon, Marc-André, Parent, Lise
Publicado 2023

Academic dependency: the influence of the prevailing international biomedical research agenda on Argentina’s CONICET

por García Carrillo, Mercedes, Testoni, Federico, Gagnon, Marc-André, Rikap, Cecilia, Blaustein, Matías
Publicado 2022

Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda

por Testoni, Federico E., García Carrillo, Mercedes, Gagnon, Marc-André, Rikap, Cecilia, Blaustein, Matías
Publicado 2021

Correction: Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda

por Testoni, Federico E., Carrillo, Mercedes García, Gagnon, Marc-André, Rikap, Cecilia, Blaustein, Matías
Publicado 2021

Pain Management Strategies After Orthopaedic Trauma: A Mixed-Methods Study with a View to Optimizing Practices

por Grzelak, Sonia, Bérubé, Mélanie, Gagnon, Marc-Aurèle, Côté, Caroline, Turcotte, Valérie, Pelet, Stéphane, Belzile, Étienne
Publicado 2022

Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study

por Grundy, Quinn, Quanbury, Ashton, Hart, Dana, Chaudhry, Shanzeh, Tavangar, Farideh, Lexchin, Joel, Gagnon, Marc-André, Tadrous, Mina
Publicado 2023

Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts

por Gleeson, Deborah, Lexchin, Joel, Labonté, Ronald, Townsend, Belinda, Gagnon, Marc-André, Kohler, Jillian, Forman, Lisa, Shadlen, Kenneth C.
Publicado 2019

Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues

por Toulouse, Jacynthe L., Yachnin, Brahm J., Ruediger, Edward H., Deon, Daniel, Gagnon, Marc, Saint-Jacques, Kévin, Ebert, Maximilian C. C. J. C., Forge, Delphine, Bastien, Dominic, Colin, Damien Y., Vanden Eynde, Jean Jacques, Marinier, Anne, Berghuis, Albert M., Pelletier, Joelle N.
Publicado 2019